Expertise in
7
conditions

Svein Dueland

Oslo, NO 
Clinical Trials:Currently Recruiting for 3 Trials
Expertise in
7
conditions
Oslo, NO 
OverviewLocationsClinical Research

Overview

Svein Dueland practices in Oslo, Norway. Dueland is highly rated in 7 conditions, according to our data. Their top areas of expertise are Colorectal Cancer, Liver Cancer, Lung Metastases, Liver Transplant, and Hepato-Pancreato-Biliary Surgery.

Their clinical research consists of co-authoring 109 peer reviewed articles and participating in 8 clinical trials. MediFind looks at clinical research from the past 15 years.

Locations

Oslo, Norway
Other Locations
Haugesund, Norway
Nydalen, 0424, Norway
Stavanger, Norway
Bjerke, 0514, Norway

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

A Phase I/II Clinical Trial to Evaluate the Benefit and Efficacy of Liver Resection And Partial Liver Segment 2/3 Transplantation With Delayed Total Hepatectomy as Treatment for Selected Patients With Liver Metastases From ColoRectal Carcinoma
A Phase I/II Clinical Trial to Evaluate the Benefit and Efficacy of Liver Resection And Partial Liver Segment 2/3 Transplantation With Delayed Total Hepatectomy as Treatment for Selected Patients With Liver Metastases From ColoRectal Carcinoma
Enrollment Status: Recruiting
Publish Date: February 06, 2024
Intervention Type: Procedure
Study Phase: Phase 1/Phase 2
A Randomized Clinical Trial Comparing Overall Survival in Selected Patients With ColoRectal Carcinoma Treated by Liver Transplantation or Chemotherapy
A Randomized Clinical Trial Comparing Overall Survival in Selected Patients With ColoRectal Carcinoma Treated by Liver Transplantation or Chemotherapy
Enrollment Status: Recruiting
Publish Date: February 06, 2024
Intervention Type: Drug, Procedure
Study Phase: Not Applicable
Liver Transplantation for Non-Resectable Intrahepatic Cholangiocarcinoma: a Prospective Exploratory Trial (TESLA Trial)
Liver Transplantation for Non-Resectable Intrahepatic Cholangiocarcinoma: a Prospective Exploratory Trial (TESLA Trial)
Enrollment Status: Recruiting
Publish Date: April 11, 2023
Intervention Type: Procedure
Study Phase: Not Applicable
A Phase 1/2 Study With BM7PE Immunotoxin in Colorectal Cancer Patients With Metastatic Disease Who Are Refractory to or With Intolerance to Last Line of Standard Chemotherapy.
A Phase 1/2 Study With BM7PE Immunotoxin in Colorectal Cancer Patients With Metastatic Disease Who Are Refractory to or With Intolerance to Last Line of Standard Chemotherapy.
Enrollment Status: Unknown
Publish Date: March 22, 2023
Intervention Type: Drug
Study Drug: BM7PE
Study Phase: Phase 1/Phase 2
Computer Navigation-assisted Surgery for Locally Advanced and Recurrent Rectal Cancer
Computer Navigation-assisted Surgery for Locally Advanced and Recurrent Rectal Cancer
Enrollment Status: Active_not_recruiting
Publish Date: November 14, 2022
Intervention Type: Device
Study Phase: Not Applicable
Trial of Vaccine Therapy in Curative Resected Prostate Cancer Patients Using Autologous Dendritic Cells Loaded With mRNA From Primary Prostate Cancer Tissue, hTERT and Survivin
Trial of Vaccine Therapy in Curative Resected Prostate Cancer Patients Using Autologous Dendritic Cells Loaded With mRNA From Primary Prostate Cancer Tissue, hTERT and Survivin
Enrollment Status: Unknown
Publish Date: September 27, 2022
Intervention Type: Biological
Study Drug: Dendritic cell vaccine
Study Phase: Phase 1/Phase 2
N-of-1 Trial of Actionable Target Identification in Metastatic Cancer for Palliative Systemic Therapy
N-of-1 Trial of Actionable Target Identification in Metastatic Cancer for Palliative Systemic Therapy
Enrollment Status: Completed
Publish Date: March 13, 2019
Intervention Type: Drug
Study Phase: Phase 2
Phase I/II Trial of MOC31PE Immunotoxin in Peritoneal Carcinomatosis From Colorectal Carcinoma
Phase I/II Trial of MOC31PE Immunotoxin in Peritoneal Carcinomatosis From Colorectal Carcinoma
Enrollment Status: Completed
Publish Date: May 30, 2017
Intervention Type: Drug
Study Phase: Phase 1/Phase 2
View 5 Less Clinical Trials

109 Total Publications

Liver transplantation for colorectal metastases following hepatic resection.
Liver transplantation for colorectal metastases following hepatic resection.
Journal: The British journal of surgery
Published: July 18, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dueland's expertise for a condition
ConditionClose
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile